Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

NanoVir LLC
Profile last edited on: 3/28/17      CAGE: 34ZL3      UEI: EFLZFF2KC7J1

Business Identifier: DNA-targeted therapeutics for human papilloma virus (HPV)
Year Founded
2003
First Award
2004
Latest Award
2012
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

4717 Campus Drive Suite 1300
Kalamazoo, MI 49008
   (269) 372-3261
   information@nanovirpharm.com
   www.nanovirpharm.com
Location: Single
Congr. District: 06
County: Kalamazoo

Public Profile

NanoVir is developing treatments for human papilloma virus (HPV) based on DNA-targeted antiviral therapeutics. The company's patent portfolio is based on the use of Polyamides for treating HPV. The company was founded by chemists affiliated with University of Missouri-St. Louis and the University of Washington.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
2
Conversion Rate
100.00%
Phase I Dollars
$780,151
Phase II Dollars
$6,829,692
Total Awarded
$7,609,843

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2012 2 NIH $3,979,193
Project Title: Antiviral Compounds that Target HPV18 DNA
2010 2 NIH $3,630,650
Project Title: Antiviral Compounds for Human Papillomavirus 16

Key People / Management

  Christopher Fisher -- Co-Founder

  James Bashkin -- Co-Founder

Company News

There are no news available.